Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Advanced Artificial Eyes is a private U.S. ocular prosthetics company and clinical ocularist practice specializing in custom-fit artificial eyes and scleral shells. The company serves patients with missing, damaged, or cosmetically disfigured eyes and markets patented Digital Iris and digital dilating pupil technologies designed to improve realism and reproducibility of prosthetic eyes. Its work is centered on direct patient care, fitting, fabrication, repair, and follow-up for ocular prostheses rather than drug development. The business appears to operate as an active commercial healthcare services and medical device provider led by board-certified ocularist John Stolpe in Southern California.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Advanced Artificial Eyes.